Management of Acute Cardiogenic Shock at the New Brunswick Heart Centre (Team-Shock)

New Brunswick Heart Centre

Status: Completed

Conditions: Cardiogenic Shock

Treatments: Other: Standard care

Study type: Observational

Funder types: Other

Identifiers

NCT05414643

101097

Details and patient eligibility

About

In Atlantic Canada, acute myocardial infarction occurs at a rate of 2.9 % of the population and is the most common cause of cardiogenic shock (CS). In many studies, acute myocardial infarction accounts for up to 80% of the patients with CS. While there are different methods of treating patients with CS, the rate of mortality has not significantly improved over the years and remains as high as 50%. Recent studies have shown that a multi-modal, team-based approach can help improve patient outcomes; however, such a standardized approach is yet to be implemented in the New Brunswick Heart Centre (NBHC).

The study aims to understand the difference in outcomes between two groups of patients treated for CS: SHOCK TEAM versus non-SHOCK TEAM. This is a retrospective study of 168 patients using the data from NBHC registry and patient charts. The study duration is 1 year. The primary outcome is hospital survival. Secondary outcomes include time from diagnosis to invasive monitoring and intervention. All data will be analyzed statistically between the two groups. The end goal of the study is to establish standard guidelines to treat CS patients and improve patient survival.

Enrollment: 1,416 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Any patient admitted to the CCU with a diagnosis of CS (SCAI groups C, D or E) at any point during their CCU care.

Exclusion criteria

1. CS patients having SCAI groups A, B (this group was used only for preliminary analysis, hence this is the exclusion criteria for all final analyses).

Trial design

1,416 participants in 2 patient groups

At- risk group (SCAI stages A, B)

Description:

Patients who had a SCAI stage A or B at any point during their stay at the New Brunswick Heart Centre, Saint John Regional Hospital. This group was compared with the cardiogenic shock group only for preliminary analysis.

Treatment:

Other: Standard care

Cardiogenic shock group (SCAI stages C-E)

Description:

Patients who had a SCAI (Society for Cardiovascular Angiography and Interventions) stage C-E at any point during their stay at the New Brunswick Heart Centre, Saint John Regional Hospital. This group was used for all subsequent analyses.

Treatment:

Other: Standard care